Archives
D-Luciferin: From Tumor Biology to Translational BLI
2026-08-22
D-Luciferin is more than a routine reagent: paired with firefly luciferase, it can connect tumor-specific genetic engineering with longitudinal functional readouts. This thought-leadership analysis examines how the PαCD3&LIGHT strategy described by He et al. could be evaluated through promoter-driven luciferase gene expression monitoring, tumor burden assessment, bioluminescence imaging, and intracellular ATP quantification. It also defines practical controls, product-handling considerations, translational limitations, and decision points for researchers moving from mechanistic discovery to reproducible preclinical evidence.
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-21
Build a dual-readout workflow that separates mRNA uptake from productive cytoplasmic translation. EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) combines direct Cy5 tracking with luciferase output for faster transfection optimization, polymer screening, and imaging studies.
Mitoxantrone: An ABCG2-Aware Assay Framework
2026-08-20
Mitoxantrone is a mechanistically rich anticancer research compound whose activity depends on both topoisomerase II engagement and intracellular drug exposure. This guide translates recent ABCG2 transporter findings into practical assay decisions while distinguishing cytotoxicity, efflux, and apoptosis.
HIV-1 Protease Autoprocessing for Drug Discovery
2026-08-20
Huang and colleagues developed and validated a cell-based AlphaLISA assay that measures HIV-1 protease precursor autoprocessing rather than only mature protease activity. The platform selectively detected known inhibitors and reproduced resistance-associated effects, providing a practical route for screening compounds that act at an early stage of protease maturation.
Pregnancy, LNP Structure, and mRNA Delivery
2026-08-19
This PNAS study shows that lipid nanoparticle structure and administration route jointly determine mRNA expression, inflammatory signaling, and maternal–fetal outcomes in pregnant mice. Its central contribution is a mechanism-based framework linking ionizable-lipid polyamine headgroups and IL-1β-associated inflammation to placental delivery, lymphoid-organ potency, immune-cell recruitment, and postnatal pup growth.
Thymoquinone Workflows for Cardiotoxicity Research
2026-08-19
Build more informative doxorubicin cardiotoxicity assays by pairing Thymoquinone with functional, redox, ferroptosis, and mitochondrial endpoints. This workflow translates mouse findings into practical formulation, dosing, controls, and troubleshooting decisions for preclinical and cell-based studies.
S. eriocheiris Entry into Drosophila S2 Cells
2026-08-18
Wei and colleagues established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris invades host cells through clathrin-mediated endocytosis and macropinocytosis. Pharmacological disruption of actin filaments and microtubules reduced intracellular bacterial numbers, linking pathogen entry and intracellular accumulation to cytoskeletal integrity.
Cy5 Maleimide and the Charge Logic of Condensates
2026-08-18
Biomolecular condensates do not merely concentrate fluorescent probes; they sort them according to physicochemical properties such as electrostatic potential. This article connects recent α-synuclein condensate findings with a practical strategy for cysteine-selective labeling using non-sulfonated Cy5 maleimide, emphasizing assay design, controls, translational boundaries, and reagent-selection tradeoffs.
EZ Cap™ Firefly Luciferase mRNA Workflow Guide
2026-08-17
Learn how to deploy EZ Cap™ Firefly Luciferase mRNA for reproducible delivery, translation, gene regulation, and imaging experiments. The workflow connects Cap1/poly(A) design with practical carrier comparisons, including acid-responsive nanoparticle strategies that can increase cytosolic RNA availability.
SU 5402: Reliable RTK Inhibition in Cell Assays
2026-08-17
This scenario-driven guide explains how SU 5402 (SKU A3843) can support receptor tyrosine kinase studies, cell-cycle analysis, apoptosis assays, and viability workflows. It emphasizes dose selection, DMSO compatibility, orthogonal readouts, and scientifically cautious interpretation.
Candida EVs, Nrg1, and Candidemia: Study Insights
2026-08-16
This study shows that high concentrations of Candida albicans extracellular vesicles suppress hyphal development by increasing the transcriptional repressor NRG1 through an SKO1- and BRG1-associated regulatory pathway. The work connects this EV-mediated morphologic effect to reduced fungal burden and improved survival in a candidemia model, while also identifying a genetic dependency on NRG1.
LNPs for Spleen-Selective mRNA Delivery
2026-08-15
The reference study introduces lipoamino bundle LNPs built from ionizable LAF-Stp carriers and evaluates them for mRNA delivery to dendritic cells, macrophages, and the spleen. Its main contribution is a chemically tunable formulation strategy that combines efficient immune-cell transfection with pronounced spleen-selective activity, while also examining serum stability and endosomal escape.
Cy5.5 NHS Ester for In Vivo Hydrogel Imaging
2026-08-14
Cy5.5 NHS ester enables covalent near-infrared labeling of proteins, peptides, and amino-modified nucleic acids for tracking nanoparticle and hydrogel behavior. This workflow translates an aged osteoarthritis nanogene-delivery concept into practical assays for retention, cellular uptake, biodistribution, and in vivo fluorescence imaging.
Early Life Adversity, Oxytocin, and Defensive Behavior
2026-08-14
This Communications Biology study identifies a circuit-level mechanism linking early life adversity with impaired visually evoked innate defensive behavior in mice. Its combination of developmental stress modeling, superior colliculus oxytocin-receptor manipulation, projection analysis, and intranasal oxytocin rescue provides a framework for studying how early experience alters threat processing.
BMN 673: From PARP Trapping to Splicing-Aware Assays
2026-08-13
BMN 673 (Talazoparib) combines exceptional PARP1/2 inhibition with pronounced PARP–DNA complex trapping. This article develops a splicing-aware framework for using the compound in DNA repair deficiency targeting, with practical guidance for hepatocellular carcinoma and other cancer models.
685 records 11/46 page Previous Next First page 上5页 1112131415 下5页 Last page